Results 71 to 80 of about 6,898 (217)
Lysophospholipids in the limelight [PDF]
The Journal of Cell Biology, 2002 Lysophosphatidic acid (LPA) is a serum phospholipid that evokes growth factor–like responses in many cell types through the activation of its G protein–coupled receptors. Although much is known about LPA signaling, it has remained unclear where and how bioactive LPA is produced. Umezu-Goto et al.
openaire +1 more source
ChemBioChem, Volume 27, Issue 11, 15 June 2026.This review reconsiders the amyloid cascade by placing lipid dynamics at its core. It shows that free lipids, governed by critical micellar concentration, act as pathological chaperones that redirect amyloid aggregation toward membrane‐damaging species.
Sofia Serravalle +6 more
wiley +1 more source
Lysophospholipid (LPA) receptors in GtoPdb v.2021.3
, 2021 Lysophosphatidic acid (LPA) receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Lysophospholipid Receptors [55, 19, 82, 129]) are activated by the endogenous phospholipid LPA.
Blaho, Victoria +7 more
core +1 more source
Bioconjugation Strategies for Revealing the Roles of Glycerophospholipids in Cells
ChemBioChem, Volume 27, Issue 11, 15 June 2026.Glycerophospholipids are the main class of phospholipids, essential for membrane structure, compartmentalization, and cellular signaling. To study their roles, innovative probes and advanced bioconjugation strategies have been developed, including by de novo lipid synthesis and bioorthogonal conjugation chemistry.
Brice Beauvais +5 more
wiley +1 more source
, 2009 Supplementary Figures S1-S5 from Anastellin, the Angiostatic Fibronectin Peptide, Is a Selective Inhibitor of Lysophospholipid ...
Anthony Ambesi (15084109) +1 more
core +1 more source
Advanced Science, Volume 13, Issue 32, 9 June 2026.Phospholipase A2 (PLA2), a dormant enzyme, becomes lethal when activated—collapsing lungs in minutes. Our dual therapy (DOPS + varespladib) boosts survival from 0% to >90% in sepsis/ALI. A breakthrough for acute lung injury treatment. ABSTRACT This study reveals that phospholipase A2 (PLA2), normally stable and nontoxic, can be activated specifically ...
Jianyu Wang +7 more
wiley +1 more source
Lysophospholipid (LPA) receptors in GtoPdb v.2021.2
, 2021 Lysophosphatidic acid (LPA) receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Lysophospholipid Receptors [55, 19, 82, 129]) are activated by the endogenous phospholipid LPA.
Blaho, Victoria +7 more
core +1 more source
Advancing design strategies in smart stimulus‐responsive liposomes for drug release and nanomedicine
BMEMat, Volume 4, Issue 2, June 2026.Schematic illustration of stimulus‐responsive liposomes designed for controlled drug release and nanomedicine. The innermost circle represents different liposomal structures, including unilamellar, multilamellar, and multivesicular liposomes. The middle layer illustrates the responsive phospholipid components.
Yuchen Guo +9 more
wiley +1 more source
, 2019 Supplemental material, TUBSupplementary_Table for The component changes of lysophospholipid mediators in colorectal cancer by Chieko Kitamura, Hirofumi Sonoda, Hiroaki Nozawa, Kuniyuki Kano, Shigenobu Emoto, Koji Murono, Manabu Kaneko, Masaya Hiyoshi ...
Kazuhito Sasaki (3362030) +15 more
core +1 more source
Lysophospholipid Metabolism and Signalling in Non-Alcoholic Fatty Liver Disease
, 2022 Non-alcoholic liver disease (NAFLD) constitutes a global health pandemic. It is estimated that about 25% of the world’s population suffers from NAFLD. In the long-term, a subgroup of the patients can develop inflammation and fibrosis.
Papadopoulos,Charalambos +3 more
core +1 more source